Codex DNA Inc (DNAY)

6.60 -0.20  -2.94% NASDAQ Nov 29, 16:00 6.585 -0.02  -0.23% Pre-Market: 20:00 USD

Codex DNA Free Cash Flow (Quarterly):

-12.98M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Free Cash Flow (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Free Cash Flow (Quarterly) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -12.98M
June 30, 2021 -6.557M
March 31, 2021 -5.216M
Dec. 31, 2020 -4.649M
Sept. 30, 2020 -3.975M
June 30, 2020 -3.558M
March 31, 2020 -3.403M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Benchmarks

LENSAR Inc -2.213M
Eargo Inc -23.69M
Movano Inc -3.313M

Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum -12.98M Sep 2021
Maximum -3.403M Mar 2020
Average -5.763M


Codex DNA acquires Eton Bioscience for ~$13M
SA Breaking News 11/10 06:17 ET
Codex DNA Acquires Eton Bioscience
Globe Newswire 11/09 16:15 ET
--Cowen Starts Codex DNA at Outperform
MT Newswires 07/13 06:53 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.